{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T09:32:55Z","timestamp":1793007175674,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Department of Education of Anhui Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112944","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:16:26Z","timestamp":1792595786000},"page":"112944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NBDP ameliorates metabolic-associated steatohepatitis by suppressing IL-17\/STAT3 signaling and caspase-mediated apoptosis"],"prefix":"10.1016","volume":"149","author":[{"given":"Ningning","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112944_bb0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41575-024-00938-9","article-title":"Envisioning how to advance the MASH field","volume":"21","author":"Allen","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0010","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated Steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellsig.2026.112944_bb0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Keam Resmetirom: first approval","volume":"84","author":"S.J","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.cellsig.2026.112944_bb0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/liv.15930","article-title":"The first MASH drug therapy on the horizon: current perspectives of resmetirom","volume":"44","author":"Petta","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.cellsig.2026.112944_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.17122","article-title":"Value-based pricing of resmetirom for metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cellsig.2026.112944_bb0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/gutjnl-2025-337431","article-title":"Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities","volume":"75","author":"Zhou","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.cellsig.2026.112944_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.20517\/mtod.2025.163","article-title":"Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy","volume":"5","author":"Fu","year":"2025","journal-title":"Metabol. Target Organ Damage"},{"key":"10.1016\/j.cellsig.2026.112944_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2025.02.008","article-title":"Kim cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum","volume":"380","author":"Hong","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.cellsig.2026.112944_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2025.01.010","article-title":"The structure of a NEMO construct engineered for screening reveals novel determinants of inhibition","volume":"33","author":"Kennedy","year":"2025","journal-title":"Structure"},{"key":"10.1016\/j.cellsig.2026.112944_bb0050","article-title":"NEMO-binding domain\/IKK\u03b3 inhibitory peptide alleviates neuronal Pyroptosis in spinal cord injury by inhibiting ASMase-induced lysosome membrane Permeabilization","volume":"11","author":"Geng","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cellsig.2026.112944_bb0055","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ijrobp.2020.11.067","article-title":"NF-\u03baB blockade by NEMO binding domain peptide ameliorates inflammation and neurobehavioral sequelae after cranial radiation therapy in juvenile mice","volume":"109","author":"Beamish","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cellsig.2026.112944_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112209","article-title":"Andrographolide sulfonate attenuates alveolar hypercoagulation and fibrinolytic inhibition partly via NF-\u03baB pathway in LPS-induced acute respiratory distress syndrome in mice","volume":"143","author":"Qian","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112944_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111569","article-title":"Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-\u03baB inactivation in ARDS mice","volume":"139","author":"Yang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112944_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124225","article-title":"Targeting NF-\u03baB by the cell-permeable NEMO-binding domain peptide improves albuminuria and renal lesions in an experimental model of type 2 diabetic nephropathy","volume":"21","author":"Opazo-R\u00edos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112944_bb0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112944_bb0080","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies","volume":"19","author":"Jos\u00e9 Mar\u00eda","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cellsig.2026.112944_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz3223","article-title":"Decoding the CHI3L1\/IL-13R\u03b12 signaling nexus in MASH-fibrosis pathogenesis","volume":"11","author":"Zheng","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellsig.2026.112944_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1437046","article-title":"Shoukry role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Abdelnabi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting Janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"2025","key":"10.1016\/j.cellsig.2026.112944_bb0100","article-title":"STAT3 signaling pathway in health and disease","volume":"6","author":"Samad","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.cellsig.2026.112944_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellsig.2026.112944_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines14030730","article-title":"Network biology and translational strategies in liver fibrosis","volume":"14","author":"Kimura","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.cellsig.2026.112944_bb0115","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e46","article-title":"IL-17 imbalance promotes the pyroptosis in immune-mediated liver injury through STAT3-IFI16 axis","volume":"23","author":"Xu","year":"2023","journal-title":"Immune Netw."},{"key":"10.1016\/j.cellsig.2026.112944_bb0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41420-024-01995-4","article-title":"IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway","volume":"10","author":"Sun","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cellsig.2026.112944_bb0125","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220681","article-title":"Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH","volume":"220","author":"Itoh","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2026.112944_bb0130","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s42255-025-01355-1","article-title":"A non-apoptotic caspase-8-meteorin pathway in hepatocytes promotes MASH fibrosis","volume":"7","author":"Wang","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cellsig.2026.112944_bb0135","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.apsb.2024.12.031","article-title":"Diabetes-associated sleep fragmentation impairs liver and heart function via SIRT1-dependent epigenetic modulation of NADPH oxidase 4","volume":"15","author":"Guo","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112944_bb0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112944_bb0145","article-title":"Ultrastructural alterations of liver tissue cells in methotrexate-treated Balb\/c mice.PG - 192-196","volume":"6","author":"Ozkorkmaz","year":"2018","journal-title":"J. Microsc. Ultrastruct."},{"key":"10.1016\/j.cellsig.2026.112944_bb0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cellsig.2026.112944_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ar.25138","article-title":"Lipid droplets, the holy grail of hepatic stellate cells: in health and hepatic fibrosis","volume":"306","author":"Mak","year":"2023","journal-title":"Anat. Rec."},{"key":"10.1016\/j.cellsig.2026.112944_bb0160","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41586-025-08677-w","article-title":"Hepatic stellate cells control liver zonation, size and functions via R-spondin 3","volume":"640","author":"Sugimoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112944_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11626-008-9166-1","article-title":"Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells","volume":"45","author":"Krause","year":"2009","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.cellsig.2026.112944_bb0170","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08493-8","article-title":"PGC-1\u03b1 protects against MASH via Tim23-dependent inhibition of DRP1-mediated ferroptosis","volume":"17","author":"Zhao","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112944_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2026.112944_bb0185","article-title":"Discovery of biophysical rate laws from the electronic health record enables real-time liver injury estimation from transaminase dynamics","volume":"5","author":"Sherman","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cellsig.2026.112944_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.cellsig.2026.112944_bb0195","article-title":"Metabolomics at the cutting edge of risk prediction of MASLD","volume":"5","author":"Tan","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cellsig.2026.112944_bb0200","article-title":"Development and validation of a noninvasive score for at-risk metabolic dysfunction-associated steatohepatitis in individuals with obesity undergoing bariatric surgery","author":"Huang","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2026.112944_bb0205","first-page":"226","article-title":"Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine","volume":"22","author":"Stefan","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0210","article-title":"Application and interpretation of non-invasive testing in MetALD","volume":"6","author":"C. WK","year":"2026","journal-title":"Metab. Target Organ Damage"},{"key":"10.1016\/j.cellsig.2026.112944_bb0215","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-026-00918-y","article-title":"The versatile interplay between steatotic liver disease and liver cancer","author":"Rahbari","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112944_bb0225","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2025.32","article-title":"Management of metabolic dysfunction and cardiovascular risk in patients with MASLD","volume":"6","author":"Danpanichkul","year":"2026","journal-title":"Metab. Target Organ Damage"},{"key":"10.1016\/j.cellsig.2026.112944_bb0230","article-title":"Carabrone attenuates metabolic dysfunction-associated steatohepatitis by targeting STAT3 in mice","volume":"6","author":"Pan","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.cellsig.2026.112944_bb0235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HEP.0000000000001309","article-title":"Neutrophil serine proteases NE and PR3 controlled by the miR-223\/STAT3 axis potentiate MASH and liver fibrosis","volume":"83","author":"Zhang","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2026.112944_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08294-5","article-title":"BRUCE liver-KO enhances MASLD\/MASH development in the steatotic PTEN-KO background by impairing mitochondrial metabolism and activating STAT3","volume":"17","author":"Che","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112944_bb0245","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-16-2253","article-title":"Multifunctional effects of a small-molecule STAT3 inhibitor on NASH and hepatocellular carcinoma in mice","volume":"23","author":"Jung","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112944_bb0250","article-title":"BRUCE liver-deficiency potentiates MASLD\/MASH in PTEN liver-deficient background by impairment of mitochondrial metabolism in hepatocytes and activation of STAT3 signaling in hepatic stellate cells","author":"Che","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.cellsig.2026.112944_bb0255","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5607\/en25020","article-title":"Robust neuroprotection by NEMO (IKK\u03b3)-binding domain peptide via anti-inflammatory effects in the post-ischemic brain","volume":"34","author":"Oh","year":"2025","journal-title":"Exp. Neurobiol."},{"issue":"Suppl. 3","key":"10.1016\/j.cellsig.2026.112944_bb0260","doi-asserted-by":"crossref","first-page":"iii75","DOI":"10.1136\/ard.2006.058438","article-title":"Use of cell permeable NBD peptides for suppression of inflammation","volume":"65","author":"Strickland","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cellsig.2026.112944_bb0265","article-title":"Bone-targeted fluoropeptide nanoparticle inhibits NF-\u03baB signaling to treat osteosarcoma and tumor-induced bone destruction","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cellsig.2026.112944_bb0270","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2119\/molmed.2013.00141","article-title":"D-amino acid substitution of peptide-mediated NF-\u03baB suppression in mdx mice preserves therapeutic benefit in skeletal muscle, but causes kidney toxicity","volume":"21","author":"Reay","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112944_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/924541","article-title":"Electroacupuncture could regulate the NF-\u03baB signaling pathway to ameliorate the inflammatory injury in focal cerebral ischemia\/reperfusion model rats","volume":"2013","author":"Qin","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.cellsig.2026.112944_bb0280","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.4049\/jimmunol.179.11.7852","article-title":"Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide","volume":"179","author":"Dav\u00e9","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0285","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/jcmm.13549","article-title":"Synovial fibroblast-targeting liposomes encapsulating an NF-\u03baB-blocking peptide ameliorates zymosan-induced synovial inflammation","volume":"22","author":"You","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112944_bb0290","article-title":"Anti-inflammatory effect of high-abundance core oligopeptides from white tea via the PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"500","author":"Zhizhan","year":"2026","journal-title":"Food Chem."},{"key":"10.1016\/j.cellsig.2026.112944_bb0295","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crfs.2021.08.008","article-title":"In silico analysis of novel dipeptidyl peptidase-IV inhibitory peptides released from Macadamia integrifolia antimicrobial protein 2 (MiAMP2) and the possible pathways involved in diabetes protection","volume":"4","author":"Zhao","year":"2021","journal-title":"Curr. Res. Food Sci."},{"key":"10.1016\/j.cellsig.2026.112944_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2026.104388","article-title":"LC-MS\/MS-based peptide identification, molecular simulations, and biological validation for targeted discovery of antioxidant peptides from large yellow croaker","volume":"39","author":"Wu","year":"2026","journal-title":"Food Chem. X"},{"key":"10.1016\/j.cellsig.2026.112944_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1656422","article-title":"The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: mechanisms and therapeutic perspectives","volume":"16","author":"Xu Lou","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0310","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41467-025-67536-4","article-title":"Zhang structural basis for ACT1 oligomerization induced by IL-17 receptor hetero-tetramer","volume":"17","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112944_bb0315","doi-asserted-by":"crossref","DOI":"10.1007\/s13679-025-00657-5","article-title":"The intriguing roles of cytokines in metabolic dysfunction-associated steatotic liver disease: a narrative review","volume":"14","author":"Vachliotis","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.cellsig.2026.112944_bb0320","article-title":"Th17\/IL-17A drives alveolar bone loss via the JAK\/STAT3-RANKL Axis in the periodontal ligament","author":"Lv","year":"2025","journal-title":"Oral Dis."},{"key":"10.1016\/j.cellsig.2026.112944_bb0325","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.4049\/jimmunol.0801882","article-title":"Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells","volume":"182","author":"Saleh","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","article-title":"IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis","volume":"20","author":"Jo","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellsig.2026.112944_bb0335","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13880209.2026.2654904","article-title":"Majoon Ushba alleviated IL-17A sensitized keratinocyte ferroptosis via JAK-2-STAT-3 signaling axis and reversed imiquimod induced psoriasiform inflammation","volume":"64","author":"Rithvik","year":"2026","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adq6406","article-title":"The tissue-specific regulation of immunobiology by IL-17 signaling","volume":"11","author":"Li","year":"2026","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0345","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jcsm.12867","article-title":"Sepsis induces interleukin 6, gp130\/JAK2\/STAT3, and muscle wasting","volume":"13","author":"Zanders","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cellsig.2026.112944_bb0350","doi-asserted-by":"crossref","first-page":"19386","DOI":"10.1074\/jbc.M112.432153","article-title":"Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor","volume":"288","author":"Floss","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2026.112944_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-026-05187-y","article-title":"Patient-derived decidual organoids reveal rhG-CSF-associated protective responses involving JAK2\/STAT3 signaling in recurrent spontaneous abortion","author":"Wei","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.cellsig.2026.112944_bb0360","article-title":"Hepatoma-derived growth factor coordinates STAT3 pathway and exosome-mediated intrahepatic crosstalk to control hepatic steatosis and MASLD","volume":"13","author":"Wen","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cellsig.2026.112944_bb0365","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s11658-025-00824-5","article-title":"CD209a regulates metabolic dysfunction-associated steatotic liver disease development through macrophage STAT3 signaling pathway","volume":"30","author":"Chen","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.cellsig.2026.112944_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08969-7","article-title":"GABRD promotes hepatocellular carcinoma progression via the IL-10RA\/JAK2-STAT3 signaling axis","volume":"17","author":"Huang","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112944_bb0375","first-page":"930","article-title":"Mouse models for the study of liver fibrosis regression in vivo and ex vivo","volume":"12","author":"Sch\u00f6nke","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0380","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1158\/1078-0432.CCR-25-0098","article-title":"FDA-AACR strategies for optimizing dosages for oncology drug products: selecting optimized dosages for registrational trials","volume":"31","author":"Shord","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112944_bb0385","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4103\/1673-5374.274324","article-title":"Large animal ischemic stroke models: replicating human stroke pathophysiology","volume":"15","author":"Kaiser","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cellsig.2026.112944_bb0390","article-title":"Muhammad recent advances in engineered exosomes for targeted microRNA delivery to reverse liver fibrosis","volume":"122","author":"Sara Mohammadi","year":"2026","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.cellsig.2026.112944_bb0395","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/HEP.0000000000000987","article-title":"Bajaj therapeutic manipulation of the microbiome in liver disease","volume":"83","author":"Parthasarathy","year":"2026","journal-title":"Hepatology"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826006042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826006042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:35:47Z","timestamp":1793003747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826006042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":79,"alternative-id":["S0898656826006042"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112944","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NBDP ameliorates metabolic-associated steatohepatitis by suppressing IL-17\/STAT3 signaling and caspase-mediated apoptosis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112944"}}